Statistics for OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH)
Total visits
views | |
---|---|
OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH) | 170 |
Total visits per month
views | |
---|---|
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
File Visits
views | |
---|---|
OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional T.pdf | 153 |
java.util.UUID:58955041-86d2-41c9-9477-5f21d1228704 | 53 |
java.util.UUID:42bb50bc-05b7-47b3-8049-e14f3cc97a54 | 18 |
java.util.UUID:8048011a-bd62-4841-b8cf-5413ac11fb39 | 10 |
Top country views
views | |
---|---|
United States | 136 |
Germany | 5 |
Ukraine | 5 |
United Kingdom | 3 |
Canada | 2 |
China | 2 |
Malaysia | 1 |
Top city views
views | |
---|---|
Wilmington | 47 |
Fairfield | 22 |
Cambridge | 12 |
Ann Arbor | 10 |
Houston | 10 |
Jacksonville | 5 |
Kiev | 5 |
Kiez | 3 |
Beijing | 2 |
Seattle | 2 |
Toronto | 2 |
Baltimore | 1 |
Bloomsbury | 1 |
Brooklyn | 1 |
Elmshorn | 1 |
Gunzenhausen | 1 |
Irvine | 1 |
Mount Laurel | 1 |
San Francisco | 1 |
Scottsdale | 1 |
Seremban | 1 |